Discontinued — last reported Q3 '22
Medtronic Derivative Assets - Net Reduction from Master Netting Arrangements increased by 9.7% to $204.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 158.2%, from $79.00M to $204.00M.
An increase suggests more effective risk mitigation through netting, while a decrease may indicate higher gross exposure or changes in counterparty credit quality.
This metric represents the reduction in gross derivative asset values resulting from legally enforceable master netting...
Standard disclosure for large global banks with significant trading and derivatives operations.
derivative_assets_net_reduction_master_netting| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $111.00M | $100.00M | $174.00M | $223.00M | $103.00M | $98.00M | $107.00M | $79.00M | $181.00M | $186.00M | $204.00M |
| QoQ Change | — | -9.9% | +74.0% | +28.2% | -53.8% | -4.9% | +9.2% | -26.2% | +129.1% | +2.8% | +9.7% |
| YoY Change | — | — | — | — | -40.8% | -56.1% | — | -23.3% | +84.7% | +73.8% | +158.2% |